Comprehensive and recent reviews converge on a model in which increased IGF-II and reduced functional IGF-I bioactivity couple to PI3K/AKT–MAPK cascades in HCC, reinforcing the conceptual importance of proteins that regulate ligand availability, such as the IGFBPs [110]. The gene discussed is IGF2; the disease is hepatocellular carcinoma.